Opportunities to Improve Fluoroquinolone Use in Adults Exist in Ambulatory Care Settings
Published March 29, 2018Systemic fluoroquinolones* (FQ) currently in use include ciprofloxacin, levofloxacin, moxifloxacin, gemifloxacin, delafloxacin and ofloxacin. These agents have a number of FDA-approved indications including respiratory tract, genitourinary tract, skin and soft-tissue, intraabdominal, and gastrointestinal tract infections. Because of ongoing safety concerns with FQ use, the FDA issued drug safety communications associated with systemically administered FQ in… Read More